Syra Health Corp. (SYRA)
0.79
+0.04
(+6.00%)
USD |
OTCM |
Nov 12, 16:00
Syra Health Gross Profit Margin (Quarterly) : 46.31% for Sept. 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 46.31% |
| June 30, 2026 | 44.50% |
| March 31, 2026 | 42.67% |
| December 31, 2025 | 14.88% |
| September 30, 2025 | 12.61% |
| June 30, 2025 | 21.61% |
| March 31, 2025 | 4.05% |
| December 31, 2024 | -4.61% |
| September 30, 2024 | 2.13% |
| Date | Value |
|---|---|
| June 30, 2024 | -26.12% |
| March 31, 2024 | -32.51% |
| December 31, 2023 | -6.23% |
| September 30, 2023 | -3.17% |
| June 30, 2023 | -45.63% |
| March 31, 2023 | -27.13% |
| June 30, 2022 | -19.70% |
| March 31, 2022 | 2.25% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Dogecoin Cash, Inc. | 22.16% |
| Privia Health Group, Inc. | 9.88% |
| Strata Critical Medical, Inc. | 15.27% |
| BrightSpring Health Services, Inc. | 12.31% |
| Cryo-Cell International, Inc. | 77.02% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 28.44% |
| Return on Assets | 19.44% |
| Return on Invested Capital | 26.64% |
| Profit Margin (Quarterly) | 13.48% |
| Operating Margin (Quarterly) | 11.73% |
| Return on Net Operating Assets | 58.66% |